Table 4.
Association between type-specific HPV seropositivity and BCC
| Controls (n=300) |
BCC (n=224) |
||
|---|---|---|---|
| HPV genus | n (%) | n (%) | OR (95% CI)1 |
|
| |||
| Any HPV type | 256 (85.3) | 203 (90.6) | 1.72 (0.96–3.05) |
|
| |||
| α | |||
|
| |||
| 2 | 29 (9.7) | 29 (12.9) | 1.55 (0.87–2.77) |
|
| |||
| 3 | 36 (12) | 43 (19.2) | 1.70 (1.03–2.82) |
|
| |||
| 7 | 22 (7.3) | 14 (6.3) | 0.87 (0.42–1.82) |
|
| |||
| 10 | 17 (5.7) | 22 (9.8) | 1.70 (0.84–3.44) |
|
| |||
| 27 | 33 (11) | 42 (18.8) | 2.18 (1.28–3.71) |
|
| |||
| 57 | 22 (7.3) | 21 (9.4) | 1.39 (0.71–2.72) |
|
| |||
| 77 | 47 (15.7) | 40 (17.9) | 1.18 (0.72–1.92) |
|
| |||
| β | |||
|
| |||
| Any β1 | 100 (33.3) | 94 (42) | 1.30 (0.89–1.90) |
|
| |||
| 5 | 38 (12.7) | 30 (13.4) | 1.01 (0.59–1.75) |
|
| |||
| 8 | 69 (23) | 69 (30.8) | 1.32 (0.87–2.00) |
|
| |||
| 20 | 63 (21) | 54 (24.1) | 1.11 (0.72–1.73) |
|
| |||
| 24 | 37 (12.3) | 42 (18.8) | 1.37 (0.82–2.28) |
|
| |||
| 36 | 52 (17.3) | 40 (17.9) | 0.90 (0.55–1.46) |
|
| |||
| Any β2 | 143 (47.7) | 114 (50.9) | 1.14 (0.79–1.64) |
|
| |||
| 9 | 75 (25) | 57 (25.4) | 0.88 (0.58–1.35) |
|
| |||
| 15 | 76 (25.3) | 67 (29.9) | 1.18 (0.78–1.77) |
|
| |||
| 17 | 77 (25.7) | 59 (26.3) | 1.06 (0.70–1.61) |
|
| |||
| 23 | 61 (20.3) | 52 (23.2) | 1.28 (0.82–1.99) |
|
| |||
| 38 | 74 (24.7) | 58 (25.9) | 1.05 (0.69–1.59) |
|
| |||
| 107 | 48 (16) | 33 (14.7) | 0.83 (0.50–1.38) |
|
| |||
| Any β3 | 101 (33.7) | 76 (33.9) | 0.96 (0.65–1.42) |
|
| |||
| 49 | 89 (29.7) | 67 (29.9) | 0.96 (0.65–1.44) |
|
| |||
| 75 | 46 (15.3) | 35 (15.6) | 1.01 (0.61–1.68) |
|
| |||
| 76 | 54 (18) | 45 (20.1) | 1.07 (0.67–1.70) |
|
| |||
| β 4 | |||
|
| |||
| (92) | 50 (16.7) | 30 (13.4) | 0.78 (0.46–1.31) |
|
| |||
| β 5 | |||
|
| |||
| (96)5 | 45 (15) | 33 (14.7) | 0.86 (0.52–1.44) |
|
| |||
| γ | |||
|
| |||
| 4 | 103 (34.3) | 84 (37.5) | 1.11 (0.76–1.62) |
|
| |||
| 48 | 64 (21.3) | 56 (25) | 1.23 (0.80–1.91) |
|
| |||
| 50 | 47 (15.7) | 34 (15.2) | 1.01 (0.61–1.67) |
|
| |||
| 65 | 78 (26) | 62 (27.7) | 0.98 (0.65–1.48) |
|
| |||
| 88 | 20 (6.7) | 13 (5.8) | 1.05 (0.49–2.24) |
|
| |||
| 95 | 67 (22.3) | 55 (24.6) | 1.00 (0.65–1.54) |
|
| |||
| 101 | 33 (11) | 24 (10.7) | 0.97 (0.54–1.74) |
|
| |||
| 103 | 13 (4.3) | 15 (6.7) | 1.37 (0.61–3.05) |
|
| |||
| Mu (1) | 96 (32) | 86 (38.4) | 1.56 (1.06–2.30) |
|
| |||
| Nu (41) | 34 (11.3) | 26 (11.6) | 1.00 (0.56–1.77) |
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval; HPV, human papillomavirus; OR, odds ratio.
1
ORs and 95% CIs adjusted for age and sex.